-
Verastem, Inc.,
doing business as
Verastem Oncology, is an
American pharmaceutical company that
develops medicines to
treat certain cancers. Headquartered...
- hit
compound identified by high-throughput screening. It was
licensed by
Verastem Oncology in 2020 for
clinical trials.
Ishii N,
Harada N,
Joseph EW, Ohara...
- 2016,
Infinity exclusively licensed the
worldwide rights to
duvelisib to
Verastem Oncology for
little money compared to
earlier deals; the deal included...
-
kinase (FAK), Pyk2, and MELK
which was
developed by
Pfizer and
licensed to
Verastem Oncology as a
potential treatment for
solid tumors.
Development for mesothelioma...
- Research.
Weinberg and Eric Lander, a
colleague at M.I.T., are co-founders of
Verastem, a
biopharmaceutical company focused on
discovering and
developing drugs...
- 2, 2007,
December 18, 2008 &
September 30, 2011 "Board of Directors".
Verastem. 2015.
Retrieved July 9, 2015. "Board of Directors".
Partners HealthCare...
- Pharmaceuticals,
Sanofi Genzyme,
Ironwood Pharmaceuticals,
Rubius Therapeutics, and
Verastem. In 2019,
according to the
NACUBO report, the
institute had an endowment...
- competitors, both
public American companies:
Stemline Therapeutics and
Verastem. By 2014, the list of
firms pursuing therapies targeting cancer stem cells...
- co-founded
VeraStem by
providing seed
funding and
office space in its own offices, with
Westphal serving as CEO and
chairman of the board;
Verastem aimed to...
- Management". Oncology. 31 (11): 821–8. PMID 29179250. "duvelisib (COPIKTRA,
Verastem, Inc.) for
adult patients with
relapsed or
refractory chronic lymphocytic...
